Concepedia

Publication | Closed Access

IMpower132: Efficacy of atezolizumab (atezo) + carboplatin (carbo)/cisplatin (cis) + pemetrexed (pem) as 1L treatment in key subgroups with stage IV non-squamous non-small cell lung cancer (NSCLC)

DOI

49

Citations

0

References

2018

Year

Fabrice Barlési, Makoto Nishio, Manuel Cobo, Nicola Steele, V.V. Paramonov, B. Parente, Rachel Dear, H. Bérard, Nir Peled, Lasika Seneviratne,
Annals of Oncology

No additional data available for this publication yet. Check back later!